Enoxaparin + warfarin + Placebo for apixaban + Placebo for enoxaparin + Placebo for warfarin + apixaban
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Venous Thrombosis
Conditions
Venous Thrombosis
Trial Timeline
Jul 1, 2008 → Mar 1, 2013
NCT ID
NCT00643201About Enoxaparin + warfarin + Placebo for apixaban + Placebo for enoxaparin + Placebo for warfarin + apixaban
Enoxaparin + warfarin + Placebo for apixaban + Placebo for enoxaparin + Placebo for warfarin + apixaban is a phase 3 stage product being developed by Pfizer for Venous Thrombosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00643201. Target conditions include Venous Thrombosis.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00643201 | Phase 3 | Completed |
Competing Products
20 competing products in Venous Thrombosis